Who are Fennec Pharmaceuticals's investors?

Fennec Pharmaceuticals's investors include Avoro Capital Advisors.

How much funding has Fennec Pharmaceuticals raised?

Fennec Pharmaceuticals has disclosed $9.8M raised across 2 rounds.

Where is Fennec Pharmaceuticals headquartered?

Fennec Pharmaceuticals is headquartered in Research Triangle Park, US.

Fennec Pharmaceuticals

Research Triangle Park, US · 1 known investors

Find your way into Fennec Pharmaceuticals

Paths you didn't know you had: your email and LinkedIn already hold routes to the Fennec Pharmaceuticals team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Fennec Pharmaceuticals develops treatments for cisplatin-induced hearing loss, a side effect of cancer chemotherapy. The company serves cancer patients undergoing treatment with cisplatin-based drugs.

Biotech Healthtech Medical Devices

Founders & leadership

Krysia LynesExecutive

Rostislav RaykovExecutive

Board

Adrian HaighBoard director

Steven SkolskyBoard director

Chris RallisBoard director

Khalid IslamBoard director

Dr. IslamChairman of the Board

Investors · 1

Avoro Capital Advisorslisted by Avoro Capital AdvisorsNew York

How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$9.8M disclosed across 2 rounds · 2014–2017

▶$7.6MraisedJun 2017 · 7 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Adrian HaighDirector
Steven SkolskyDirector
Chris RallisDirector
Krysia LynesExecutive Officer
Rostislav RaykovExecutive Officer, Director
Khalid IslamDirector

Offering amount: $7.6M
Amount sold: $7.6M
First sale: Jun 2017
Incorporated: Corporation, British Columbia, Canada
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.2MraisedDec 2014 · 22 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Adrian HaighDirector
Khalid IslamDirector
Rostislav RaykovExecutive Officer, Director
Steven SkolskyDirector
Krysia LynesExecutive Officer
Chris RallisDirector

Offering amount: $2.2M
Amount sold: $2.2M
First sale: Dec 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 8

NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.

Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.

PublicPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.

Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.

TipRanksFinancial analysis and stock research platform.

TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.

StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.

Companies working in the same space as Fennec Pharmaceuticals.

Frequently asked questions

What does Fennec Pharmaceuticals do?: Fennec Pharmaceuticals develops treatments for cisplatin-induced hearing loss, a side effect of cancer chemotherapy. The company serves cancer patients undergoing treatment with cisplatin-based drugs.
Who are Fennec Pharmaceuticals's investors?: Fennec Pharmaceuticals's investors include Avoro Capital Advisors.
How much funding has Fennec Pharmaceuticals raised?: Fennec Pharmaceuticals has disclosed $9.8M raised across 2 rounds.
Where is Fennec Pharmaceuticals headquartered?: Fennec Pharmaceuticals is headquartered in Research Triangle Park, US.